AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « human »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
huge < human < humanistic  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]
Ident.Authors (with country if any)Title
000000 (2020) Cheng Liu [République populaire de Chine] ; Xiaojun Guo [République populaire de Chine] ; Sunpeng Bai [République populaire de Chine] ; Guangjun Zeng [République populaire de Chine] ; Hao Wang [République populaire de Chine]lncRNA CASC2 downregulation participates in rheumatoid arthritis, and CASC2 overexpression promotes the apoptosis of fibroblast-like synoviocytes by downregulating IL-17
000017 (2020) Franziska Düver [Allemagne] ; Benedikt Wei Brich [Allemagne] ; Matthias Eyrich [Allemagne] ; Matthias Wölfl [Allemagne] ; Paul G. Schlegel [Allemagne] ; Verena Wiegering [Allemagne]Viral reactivations following hematopoietic stem cell transplantation in pediatric patients – A single center 11-year analysis
000080 (2020) Maria Valeria Catani ; Isabella Savini ; Valentina Tullio ; Valeria GasperiThe “Janus Face” of Platelets in Cancer
000084 (2020) Matthew Zirui Tay [Singapour] ; Chek Meng Poh [Singapour] ; Laurent Rénia [Singapour] ; Paul A. Macary [Singapour] ; Lisa F. P. Ng [Singapour, Royaume-Uni]The trinity of COVID-19: immunity, inflammation and intervention
000090 (2020) Muneyoshi Futami [Japon] ; Keisuke Suzuki [Japon] ; Satomi Kato [Japon] ; Saori Ohmae [Japon] ; Yoshio Tahara [Japon] ; Masanori Nojima [Japon] ; Yoichi Imai [Japon] ; Takayuki Mimura [Japon] ; Yoshihiro Watanabe [Japon] ; Arinobu Tojo [Japon]The novel multi-cytokine inhibitor TO-207 specifically inhibits pro-inflammatory cytokine secretion in monocytes without affecting the killing ability of CAR T cells.
000093 (2020) Yuan-Yang Cheng [Taïwan] ; Shin-Tsu Chang [Taïwan] ; Chung-Lan Kao [Taïwan] ; Yi-Huei Chen [Taïwan] ; Ching-Heng Lin [Taïwan]The impact of rehabilitation frequency on the risk of stroke in patients with rheumatoid arthritis
000097 (2020) Weiyi Tan ; Jamil AboulhosnThe cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
000105 (2020) Peter J. Hotez ; Maria Elena Bottazzi ; David B. CorryThe Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
000123 (2020) Huizhi Wang ; Zihang Chen ; Shaobo Wang ; Xiao Gao ; Mingyu Qian ; Wei Qiu ; Zongpu Zhang ; Shouji Zhang ; Yanhua Qi ; Xiaopeng Sun ; Hao Xue ; Xing Guo ; Rongrong Zhao ; Gang LiTGFβ1‐induced beta‐site APP‐cleaving enzyme 2 upregulation promotes tumorigenesis through the NF‐κB signalling pathway in human gliomas
000124 (2020) Lanlan Fang ; Yiran Li ; Sijia Wang ; Yuxi Li ; Hsun-Ming Chang ; Yuyin Yi ; Yang Yan ; Avinash Thakur ; Peter C. K. Leung ; Jung-Chien Cheng ; Ying-Pu SunTGF-β1 induces VEGF expression in human granulosa-lutein cells: a potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome
000125 (2020) Gali Epstein Shochet [Israël] ; Elizabetha Brook [Israël] ; Becky Bardenstein-Wald [Israël] ; David Shitrit [Israël]TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling
000159 (2020) Cem Gabay [Suisse] ; Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Toshio Kimura [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Susan H. Boklage [États-Unis] ; Jonathan Sadeh [États-Unis] ; Neil M. H. Graham [États-Unis] ; Anita Boyapati [États-Unis]Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes
000172 (2020) Di Mauro Gabriella ; Scavone Cristina ; Rafaniello Concetta ; Rossi Francesco ; Capuano AnnalisaSARS-Cov-2 infection: response of human immune system and possible implications for the rapid test and treatment
000179 (2020) Carolina Caro-Vegas [États-Unis] ; Subhashini Sellers [États-Unis] ; Kurtis M. Host [États-Unis] ; Jedediah Seltzer [États-Unis] ; Justin Landis [États-Unis] ; William A. Fischer [États-Unis] ; Blossom Damania [États-Unis] ; Dirk P. Dittmer [États-Unis]Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.
000200 (2020) Gregory M. Constantine [États-Unis] ; Michail S. Lionakis [États-Unis]Recent advances in understanding inherited deficiencies in immunity to infections
000223 (2020) Chih-Chia Lu [République populaire de Chine] ; Mei-Yu Chen [République populaire de Chine] ; Yuh-Lih ChangPotential therapeutic agents against COVID-19: What we know so far
000225 (2020) Ali Rismanbaf [Iran]Potential Treatments for COVID-19; a Narrative Literature Review
000226 (2020) Marie Febvre-James [France] ; Valérie Lecureur [France] ; Olivier Fardel [France]Potent repression of C-reactive protein (CRP) expression by the JAK1/2 inhibitor ruxolitinib in inflammatory human hepatocytes.
000251 (2020) Simona Di Giambenedetto ; Arturo Ciccullo ; Alberto Borghetti ; Giovanni Gambassi [Italie] ; Francesco Landi [Italie] ; Elena Visconti ; Lorenzo Zileri Dal Verme ; Roberto Bernabei [Italie] ; Enrica Tamburrini ; Roberto Cauda ; Antonio Gasbarrini [Italie]Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection.
000310 (2020) Guoqiang Zhang [République populaire de Chine] ; Hayato Iwase [États-Unis] ; Liaoran Wang [États-Unis] ; Takayuki Yamamoto [États-Unis] ; Abhijit Jagdale [États-Unis] ; David Ayares [États-Unis] ; Yong Li [République populaire de Chine] ; David K C. Cooper [États-Unis] ; Hidetaka Hara [États-Unis]Is interleukin-6 receptor blockade (tocilizumab) beneficial or detrimental to pig-to-baboon organ xenotransplantation?
000318 (2020) Peter Uciechowski [Allemagne] ; Wolfram C M. Dempke [Allemagne]Interleukin-6: A Masterplayer in the Cytokine Network.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "human" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "human" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    human
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021